Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

Keytruda Demonstrates Significant Improvement for Some Patients with Melanoma

June 9th 2022

Keytruda, an immunotherapy agent, demonstrated significant improvement in both distant metastasis-free survival and recurrence-free survival compared to placebo.

Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations

May 25th 2022

Patients can still talk to their clinicians about enrolling in a sub-study of the FIRELIGHT-1 trial, analyzing tovorafenib plus pimasertib in progressive or refractory solid tumors with MAPK pathway aberrations.

PGA Tour Golfer Justin Thomas Urges People to Check for Melanoma, ‘One Life to Live’ and ‘As the World Turns’ Actress Marnie Schulenburg Dies from Cancer and More

May 20th 2022

From PGA Tour golfer Justin Thomas’ new sun-protection line to soap opera actress Marnie Schulenburg’s breast cancer death and the first child to receive CAR-T cell therapy celebrating 10 years cancer-free, here’s what’s happening in the cancer space this week.

No Matter the Obstacle Thrown in Our Faces, Cancer Advocates Will Always Succeed

May 13th 2022

I like to think that cancer advocates live the motto of the postal service, “Neither snow nor rain nor heat nor gloom of night stays these couriers from their swift completion of their appointed rounds.”

First-in-Human Trial Assessing Novel Drug in Patients With Solid Tumors Launches

May 12th 2022

The primary objective of the early-stage trial is to determine the maximum tolerated dose of the novel drug in a group of patients with recurrent and/or refractory solid tumors.

Skin Cancer Diagnosis, Older Age May Be Associated With Increased Risk for Rare Skin Condition from Immunotherapy Treatment

April 19th 2022

Patients within the study who developed the rare skin condition were more likely to experience better tumor responses than those who did not develop the side effect.

I Have Some Regrets Around How I Handled My Wife’s Cancer

April 17th 2022

Upon reflecting on my late wife's cancer experience, one of my major regrets is not properly saying goodbye.

Opdivo-Yervoy Combo Induces Survival Benefit in Advanced Skin Cancer

April 14th 2022

Compared with Yervoy alone, the use of Yervoy plus Opdivo was associated with a significant survival benefit as a second-line treatment in patients with previously treated advanced melanoma, a type of skin cancer.

Trial of Direct-to-Tumor Skin Cancer Drug Doses First Patient

April 7th 2022

A phase 2 trial will investigate LTX-315 in patients with basal cell carcinoma, the most common form of skin cancer.

Early-Stage Clinical Trial Treats First Patient With Life-Threatening Cancer Metastases With Investigational Drug

March 30th 2022

It is expected that up to 18 patients with leptomeningeal metastases — a serious form of cancer that has spread from its original location to an area surrounding the brain and spinal cord — will receive treatment with the investigational drug.

Cancer Conferences Helped Me Grow as an Advocate

March 25th 2022

At first, I struggled to keep up with the scientific jargon being presented at a cancer conference, but eventually I hit my stride and now I leave these events with a renewed sense of inspiration.

Swapping Surgery for Adjuvant Therapy May Improve Outcomes in Patients With Stage 3 Melanoma

March 23rd 2022

Patients with stage 3 melanoma, a type of skin cancer, that has metastasized to the lymph nodes may benefit from skipping lymph node removal surgery and receiving treatment with adjuvant therapy, although more research is needed in this area.

Opdivo Plus Experimental Drug Combo Fails to Improve Survival, Response Rates in Patients With Advanced Melanoma

March 22nd 2022

The use of bempegaldesleukin and Opdivo failed to meet its goal of significantly improving progression-free survival and responses to treatment, compared with Opdivo alone in patients with previously untreated unresectable or metastatic melanoma, according to data from an initial analysis of the phase 3 PIVOT IO-001 study.

FDA Approves Opdualag, a New Fixed-Dose Combination Treatment, For Certain Patients With Skin Cancer

March 19th 2022

The FDA’s decision to greenlight Opdualag is based on data that showed that the combination more than doubled survival without disease progression when compared with Opdivo in patients with previously untreated metastatic or unresectable melanoma, a type of skin cancer.

Opdivo-Based Combo Continues to Improve Survival Outcomes in Previously Untreated Patients With Metastatic or Unresectable Melanoma

March 16th 2022

The findings, according to the study’s lead author, justify the use of Opdivo plus relatlimab as a new treatment option for patients with advanced melanoma, a form of skin cancer.

Invading Cancer Cells With Immunotherapy Combinations

March 16th 2022

Recent research has demonstrated the ability of immunotherapy combinations to target advanced melanoma.

Cancerphobic: How My Cancer History Put Me on ‘High Alert’ for Potential New Diagnoses

March 14th 2022

When two small spots appeared on my face, I couldn’t help but wonder if they might be cancerous. Had I failed to protect my skin with a hat or sunscreen? Suddenly, I was cancerphobic.

Decades' Worth of Reconstruction Advancements Have Transformed the Lives of Many Patients Who Underwent Debilitating Cancer Treatments

March 10th 2022

Aesthetic appearances, according to an expert at the UCSF, are often important for patients following the surgical treatment of cancer. Advancements in this space over the past 20 years have allowed many to patients to look as normal as possible.

Keytruda Lengthens Time Until Distant Metastases Appear in Patients With Melanoma

March 7th 2022

The time patients with resected melanoma, a type of skin cancer, lived without their disease spreading to distant organs improved drastically after treatment with Keytruda.

Leptomeningeal Disease: A Rare Cancer Metastasis

March 2nd 2022

The number of people developing leptomeningeal disease is increasing for the same reason that diagnoses of brain metastases are on the rise: People are living longer, giving cancer more time to spread.

‘Tremendous Hope’ Surrounds Emerging Therapies for Cancer That has Spread to the Brain

March 1st 2022

Better therapies are on the horizon for cancer that has spread to the brain, including a clinical trial that matches patients with treatments based on unique genetic changes in brain metastases.

Photoimmunotherapy Trial Begins in Certain Patients With Head and Neck, and Skin Cancer

February 22nd 2022

The goal of the phase 2 trial is to study the safety and efficacy of ASP-1929, a photoimmunotherapy with fluorescence imaging, in patients with head and neck or skin cancer.

What I Learned About Diversity, Equity and Inclusion in the Skin Cancer Space

February 11th 2022

I learned that a more prominent obstacle that we need to navigate is getting past the assumption that having a darker skin tone protects people from skin cancer.

Skin-Related Side Effects From a Certain Cancer Treatment May Indicate Stronger Responses, Survival

January 28th 2022

Side effects from cancer treatment with immunotherapy, which may include vitiligo and certain rashes, may point to who will respond better to the treatment, although more research is needed to determine how much weight to put on these data.

FDA Approves Kimmtrak for Unresectable or Metastatic Uveal Melanoma

January 26th 2022

Kimmtrak is the first-ever drug to be granted FDA approval for this patient population of HLA-A*02:01-positive metastatic or unresectable uveal melanoma.

Cosibelimab Elicits Positive Tumor Response in Patients With Metastatic Skin Cancer Subtype

January 25th 2022

Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

Ronnie Spector Dies After Brief Spell With Cancer, Man Continues His Personal Health Advocacy After a Stranger Helped Discover His Cancer and More

January 14th 2022

From the deaths of singer Ronnie Spector and famed cancer researcher Beatrice Mintz to a patient who became his own biggest advocate after a stranger noticed a suspicious spot on his back, here’s what’s happening in the cancer landscape this week.

Increased Fiber Intake May Improve Immunotherapy Responses in Patients With Skin Cancer Subtype

January 10th 2022

Patients with melanoma who consumed a high-fiber diet may have a better response to immunotherapy, although the benefit was not as great if the fiber was obtained via probiotic supplements.

FDA Target Dates for Potential Cancer Drug Approvals in Early 2022

January 10th 2022

The Food and Drug Administration is expected to decide on whether to approve certain cancer regimens within the first few months of the year. Here’s what patients with cancer should know.

New Drug Combo Boasts Improved Outcomes, Fewer Side Effects in Melanoma

January 7th 2022

Relatlimab plus Opdivo improved progression-free survival in patients with untreated, advanced melanoma, and tended to have fewer side effects than other regimens used in this patient population.

NEXT PAGE
PREVIOUS PAGE